Tasly Pharmaceutical Group Co (SHSE:600535) Cyclically Adjusted Book per Share: ¥7.77 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600535 Tasly Pharmaceutical Group Co Ltd SHSE:600535
81 GF Score
Price ¥14.59
GF Value ¥15.06
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Tasly Pharmaceutical Group Co Cyclically Adjusted Book per Share?

Tasly Pharmaceutical Group Co SHSE:600535 +1.46% 81 Cyclically Adjusted Book per Share is ¥7.77 as of Mar. 2026. GuruFocus rates SHSE:600535 with a GF Score™ of 81/100 and a GF Value™ of ¥15.06 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Tasly Pharmaceutical Group Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥8.546. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥7.77 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Tasly Pharmaceutical Group Co's average Cyclically Adjusted Book Growth Rate was 4.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Tasly Pharmaceutical Group Co was 17.50% per year. The lowest was 6.50% per year. And the median was 15.05% per year.

As of today (2026-07-14), Tasly Pharmaceutical Group Co's current stock price is ¥14.59. Tasly Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥7.77. Tasly Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is 1.88.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tasly Pharmaceutical Group Co was 11.91. The lowest was 1.55. And the median was 2.56.


Tasly Pharmaceutical Group Co  (SHSE:600535) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Tasly Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=14.59/7.77
=1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tasly Pharmaceutical Group Co was 11.91. The lowest was 1.55. And the median was 2.56.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Tasly Pharmaceutical Group Co Cyclically Adjusted Book per Share Related Terms


Tasly Pharmaceutical Group Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Tasly Pharmaceutical Group Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tasly Pharmaceutical Group Co Cyclically Adjusted Book per Share Chart

Tasly Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.75 6.35 6.84 7.32 7.67

Tasly Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.41 7.47 7.58 7.67 7.77

SHSE:600535 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tasly Pharmaceutical Group Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tasly Pharmaceutical Group Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tasly Pharmaceutical Group Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Tasly Pharmaceutical Group Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600535
81GF Score
Tasly Pharmaceutical Group Co Ltd SHSE:600535
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tasly Pharmaceutical Group Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tasly Pharmaceutical Group Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.546/116.3033*116.3033
=8.546

Current CPI (Mar. 2026) = 116.3033.

Tasly Pharmaceutical Group Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 5.068 101.400 5.813
201609 5.279 102.400 5.996
201612 5.265 102.600 5.968
201703 5.475 103.200 6.170
201706 5.367 103.100 6.054
201709 5.620 104.100 6.279
201712 5.721 104.500 6.367
201803 5.968 105.300 6.592
201806 6.062 104.900 6.721
201809 6.861 106.600 7.486
201812 6.964 106.500 7.605
201903 7.275 107.700 7.856
201906 7.258 107.700 7.838
201909 7.352 109.800 7.787
201912 7.359 111.200 7.697
202003 7.555 112.300 7.824
202006 7.531 110.400 7.934
202009 7.737 111.700 8.056
202012 7.915 111.500 8.256
202103 8.122 112.662 8.385
202106 8.199 111.769 8.532
202109 8.541 112.215 8.852
202112 8.582 113.108 8.824
202203 8.220 114.335 8.362
202206 8.024 114.558 8.146
202209 8.144 115.339 8.212
202212 8.277 115.116 8.362
202303 8.375 115.116 8.461
202306 8.123 114.558 8.247
202309 8.270 115.339 8.339
202312 8.247 114.781 8.356
202403 8.473 115.227 8.552
202406 8.388 114.781 8.499
202409 8.506 115.785 8.544
202412 7.968 114.893 8.066
202503 7.979 115.116 8.061
202506 8.285 114.907 8.386
202509 8.236 115.471 8.295
202512 8.303 115.832 8.337
202603 8.546 116.303 8.546

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥7.77 mean?
Tasly Pharmaceutical Group Co (SHSE:600535) has a Cyclically Adjusted Book per Share of ¥7.77 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Tasly Pharmaceutical Group Co and its competitors.
Is Tasly Pharmaceutical Group Co's Cyclically Adjusted Book per Share too high?
Tasly Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is ¥7.77. Overall, Tasly Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tasly Pharmaceutical Group Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Tasly Pharmaceutical Group Co's Cyclically Adjusted Book per Share of ¥7.77 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Tasly Pharmaceutical Group Co and its competitors. Tasly Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is ¥7.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tasly Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Tasly Pharmaceutical Group Co (SHSE:600535) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.06, compared to a current price of ¥14.59 — trading 3.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥7.77. Tasly Pharmaceutical Group Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Tasly Pharmaceutical Group Co (SHSE:600535), the current Cyclically Adjusted Book per Share is ¥7.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tasly Pharmaceutical Group Co (SHSE:600535) Overvalued in 2026?

Based on GuruFocus' analysis, Tasly Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥14.59 is trading 3.1% below its estimated GF Value™ of ¥15.06. GuruFocus considers Tasly Pharmaceutical Group Co to be Fairly Valued.

Key valuation signals for SHSE:600535:

  • Cyclically Adjusted Book per Share: ¥7.77
  • GF Value™: ¥15.06 vs. price of ¥14.59 (3.1% below fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the SHSE:600535 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tasly Pharmaceutical Group Co Business Description

Address 2 Pujihe Road East, Beichen District, Tasly TCM Garden, Tianjin, CHN, 300410
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.
81GF Score

Get the complete analysis for SHSE:600535

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.59
Price
¥15.06
GF Value